Literature DB >> 18654917

Schizophyllum commune: an unusual of agent bronchopneumonia in an immunocompromised patient.

Vivian Tullio1, Narcisa Mandras, Giuliana Banche, Valeria Allizond, Ester Gaido, Janira Roana, Anna Maria Cuffini, Nicola A Carlone.   

Abstract

We report a case of bronchopneumonia due to Schizophyllum commune in an immunocompromised patient. While this fungus rarely causes disease in humans, it has been reported in association with several clinical entities and lung disorders. A 59-year-old white man with a gastric carcinoma was admitted to S. Giovanni Battista Hospital (Turin, Italy). Three days after the admission, he developed a bronchopneumonia, which was diagnosed through the use of X-ray and showed an abnormal infiltrative shadow. Samples of bronchial aspirate were collected for laboratory microbiological investigation. Direct microscopic examination of these specimens revealed the presence of numerous septate, hyaline hyphae and rare clamp connections. Sabouraud Dextrose Agar and Columbia agar plus 5% blood media inoculated with portions of the same specimens yielded, after 4-5 days of incubation at 25 degrees C and 37 degrees C, a cottony white mould. The fungus was identified on the basis of its macroscopic and microscopic morphology. The macroscopic examination of the colony showed raised, curved, fan-shaped and shell-like basidiocarps. The microscope examination revealed the presence of hyaline, septate hyphae with clamp connections and short, thin spicules. The fungal isolate was identified as S. commune. The patient was cured after therapy with intravenous fluconazole (600 mg twice daily for over six weeks).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18654917     DOI: 10.1080/13693780802256091

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  7 in total

Review 1.  First report of otitis externa caused by Schizophyllum commune and review of the literature.

Authors:  Tadeja Matos; Rok Tomazin; Saba Battelino
Journal:  Wien Klin Wochenschr       Date:  2016-01-22       Impact factor: 1.704

2.  Molecular characterization and in vitro antifungal susceptibility profile of Schizophyllum commune, an emerging basidiomycete in bronchopulmonary mycoses.

Authors:  Anuradha Chowdhary; Shallu Kathuria; Pradeep Kumar Singh; Kshitij Agarwal; Shailendra N Gaur; Pradip Roy; Harbans S Randhawa; Jacques F Meis
Journal:  Antimicrob Agents Chemother       Date:  2013-03-18       Impact factor: 5.191

3.  Filamentous Basidiomycetes in the Clinical Laboratory.

Authors:  Mary E Brandt
Journal:  Curr Fungal Infect Rep       Date:  2013-07-13

4.  Fatal empyema thoracis caused by Schizophyllum commune with cross-reactive cryptococcal antigenemia.

Authors:  Jasper F W Chan; Jade L L Teng; Iris W S Li; Sally C Y Wong; Sally S M Leung; Po-On Ho; Kelvin K W To; Susanna K P Lau; Patrick C Y Woo; Kwok-Yung Yuen
Journal:  J Clin Microbiol       Date:  2013-11-13       Impact factor: 5.948

5.  Uses and importance of wild fungi: traditional knowledge from the Tshopo province in the Democratic Republic of the Congo.

Authors:  Héritier Milenge Kamalebo; Hippolyte Nshimba Seya Wa Malale; Cephas Masumbuko Ndabaga; Jérôme Degreef; André De Kesel
Journal:  J Ethnobiol Ethnomed       Date:  2018-02-12       Impact factor: 2.733

6.  First report on cutaneous infectious granuloma caused by Schizophyllum commune.

Authors:  Lidi Tian; Yunzhu Mu; Hao Zhang; Xiaocui Su; Chuan Yang; Xianzhu Shu; Defu Qing
Journal:  BMC Infect Dis       Date:  2018-06-26       Impact factor: 3.090

7.  Pneumonia due to Schizophyllum commune in a Patient with Acute Myeloid Leukemia: Case Report and Literature Review.

Authors:  Hahn Kim; Yunmi Yi; Sung-Yeon Cho; Dong-Gun Lee; Hye-Sun Chun; Chulmin Park; Yoo-Jin Kim; Yeon-Joon Park
Journal:  Infect Chemother       Date:  2020-09-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.